Association of XRCC5 VNTR polymorphism with the development of chronic myeloid leukemia

By Gorre Manjula   Mohandas Prajitha   Kagita Sailaja   Annamaneni Sandhya   Digumarti Raghunadharao   Satti Vishnupriya  

Tumor Biology, Vol. 35, Iss. 2, 2014-02 ,pp. : 923-927

Springer Publishing Company

Access to resources Recommend Favorite

Imatinib Mesylate: A Review of Its Use in Chronic Myeloid Leukemia

By Curran M.P.   Croom K.F.   Goa K.L.  

American Journal of Cancer, Vol. 2, Iss. 6, 2003-01 ,pp. : 439-454

Adis International

Access to resources Recommend Favorite

Advances in the biology and therapy of chronic myeloid leukemia: proceedings from the 6th Post-ASH International Chronic Myeloid Leukemia and Myeloproliferative Neoplasms Workshop

By van Etten Richard A.  

Leukemia and Lymphoma, Vol. 54, Iss. 6, 2013-06 ,pp. : 1151-1158

Informa Healthcare

Access to resources Recommend Favorite

Increased BCR promoter DNA methylation status strongly correlates with favorable response to imatinib in chronic myeloid leukemia patients

By                    

Oncology Letters, Vol. 2, Iss. 1, 2011-01 ,pp. : 181-187

Spandidos Publications

Access to resources Recommend Favorite

Instability of mRNA expression signatures of drug transporters in chronic myeloid leukemia patients resistant to imatinib

By                    

Oncology Reports, Vol. 29, Iss. 2, 2013-01 ,pp. : 741-750

Spandidos Publications

Access to resources Recommend Favorite